U.S., April 18 -- ClinicalTrials.gov registry received information related to the study (NCT03912844) titled 'European SIR-Spheres Surgical Registry' on April 3.
Brief Summary: Liver resection is the only curative treatment option for primary and secondary liver tumors. For some primary or secondary malignancies (HCC, NET) liver transplantation is a possible treatment option. Unfortunately, the majority of patients show a high hepatic tumor load or adverse intrahepatic distribution, that resection or transplantation at the time of initial diagnosis is not possible. In that case different treatment approaches are possible. For those patients that are very unlikely to ever become resectable, palliative systemic therapy is the preferred treat...